Value of Tomosynthesis for the Detection of Sacro-iliitis (TOMOS SI)
TOMOS SI
Value of Tomosynthesis for Detection of Sacro-iliitis: a Prospective Comparative Study
1 other identifier
interventional
30
1 country
1
Brief Summary
Spondyloarthropathies (SpAs) are chronic inflammatory diseases encompassing ankylosing spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthropathy, and undifferentiated SpA. In 2001, the estimated prevalence of SpA was 1.5% worldwide. Sacroiliitis is a condition caused by inflammation within the sacroiliac joint. It is the most frequent damage of SpA depicted at imaging evaluation. Conventional radiography (X-ray) is usually used to depict the structural changes associated with sacroiliitis. However further evaluation often requires additionnal computed tomography (CT). Tomosynthesis is an Xray-based imaging technology which allows reconstruction of multiple section images from a set of projection images acquired as the x-ray tube moves along a prescribed path. The advantagee of tomosynthesis is the significant reduction of radiation dose exposure compared to CT Tomosynthesis is currently used in the field of breast imaging and pneumology. Very few studies have examined the value of tomosynthesis for osteoarticular imaging. The study aims at evaluating the diagnostic performances of tomosynthesis as compared to standard X-ray and CT, in patients with a clinical suspicion of sacroiliitis. the investigators hypothesize that tomosynthesis is superior to conventional radiography for detection of sacroiliitis and is at least equal to CT with lower irradiation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2018
CompletedFirst Posted
Study publicly available on registry
October 1, 2018
CompletedStudy Start
First participant enrolled
October 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedSeptember 27, 2019
September 1, 2018
1.2 years
September 27, 2018
September 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of bone erosions and other structural lesions of SI joints
sacroiliitis will be assessed independently for each imaging modality according to the modified New York criteria
1 day of enrollment
Secondary Outcomes (2)
radiation dose
1 day of enrollment
inter reader agreement for the evaluation of sacroiliitis at tomosynthesis
at the end of patients enrollment
Study Arms (1)
Tomosynthesis
EXPERIMENTALTomosynthesis of SI joints
Interventions
All patients will undergo additional tomosynthesis performed per study protocol along with Xray and CT performed as part of standard imaging evaluation of sacroillitis. Tomosynthesis of SI joints will be performed on a digital Tomosynthesis system (PLATINUM dRF v2 DMS/APELEM), with a single acquisition followed by coronal image reconstruction.
Eligibility Criteria
You may qualify if:
- Patients aged 18 and over referred for suspected sacroiliitis.
- Patients who have entered into their participation agreement by signing the informed consent form.
- Patient affiliated to a social security scheme or beneficiary.
You may not qualify if:
- Pregnant or lactating women.
- Vulnerable people according.
- Major people placed under guardianship or curatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- DMS Apelemcollaborator
- Thalescollaborator
- Digisenscollaborator
- Medecomcollaborator
- BPIfrancecollaborator
- European Regional Development Fundcollaborator
Study Sites (1)
Imaging department- University hospital
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Cyteval, MD, PhD
Montpellier University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2018
First Posted
October 1, 2018
Study Start
October 4, 2018
Primary Completion
December 31, 2019
Study Completion
December 31, 2020
Last Updated
September 27, 2019
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share